Bristol-Myers Squibb to close Irish plant


Bristol-Myers Squibb (BMS) is to close its manufacturing plant in Cruiserath, Ireland, with the loss of 130 jobs by the end of 2015. A further 30 positions will be cut at the nearby plant in Swords as one of several operating units on that site is also shuttered.

BMS tied the closures to ‘changing market demand’ for its products, along with efforts to optimise its manufacturing network. The remaining 320 employees at the Swords plant will continue to manufacture bulk pharmaceuticals.

Susan Hynes, BMS’s general manager of active pharmaceutical ingredient operations Ireland, said in a statement that ‘the company is working to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland’.


Related Content

BMS invests in gene therapy

9 April 2015 Business

news image

Bristol-Myers Squibb makes $100 million deal with biotech uniQure

BMS sells OTC drugs for $482m

14 February 2013 Business

news image

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser

Most Read

First pictures of hydrogen bonds unveiled

26 September 2013 Research

news image

Observation of intermolecular interactions in quinolines could help to settle the nature of this kind of bonding

Copper catalysis overcomes double bond trouble

3 July 2015 Research

news image

Stubbornly stable unactivated internal alkenes become chiral tertiary amine precursors

Most Commented

Collaboration, not competition

29 June 2015 Research

news image

Organic chemist E J Corey talks to Phillip Broadwith about awards, ambition and academic freedom

Z machine puts the squeeze on metallic deuterium

25 June 2015 Research

news image

Pressures similar to those at centre of the Earth forge metallic deuterium in step toward 80-year-old dream of creating metal...